Q4 2023 Holdings
Filed 2024-02-13 | 64 holdings | $1.8B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics Inc | COM | 48576A100 | $437.1M | 1,381,149 | 24.5% |
| RayzeBio Inc | COM | 75525N107 | $150.4M | 2,419,528 | 8.4% |
| Natera Inc(NTRA) | COM | 632307104 | $97.1M | 1,550,280 | 5.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $95.0M | 754,032 | 5.3% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $93.5M | 857,971 | 5.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $85.1M | 3,758,686 | 4.8% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $57.3M | 850,577 | 3.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $53.3M | 3,467,156 | 3.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $51.9M | 1,458,881 | 2.9% |
| ImmunoGen Inc(IMGNEUR) | COM | 45253H101 | $45.9M | 1,546,902 | 2.6% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $42.8M | 126,959 | 2.4% |
| Eli Lilly & Co(LLY) | COM | 532457108 | $37.6M | 64,525 | 2.1% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $34.6M | 414,207 | 1.9% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $33.5M | 844,008 | 1.9% |
| CymaBay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $33.3M | 1,411,769 | 1.9% |
| Immatics NV(IMTX) | SHS | N44445109 | $31.3M | 2,969,039 | 1.7% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $29.8M | 598,978 | 1.7% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $29.4M | 772,957 | 1.6% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $26.0M | 1,206,939 | 1.5% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $24.0M | 1,667,321 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $23.2M | 1,075,786 | 1.3% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $19.3M | 1,772,699 | 1.1% |
| Stryker Corporation(SYK) | COM | 863667101 | $18.8M | 62,788 | 1.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $18.6M | 296,569 | 1.0% |
| Geron Corp(GERN) | COM | 374163103 | $18.6M | 8,814,497 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $18.2M | 4,280,308 | 1.0% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $17.8M | 1,193,885 | 1.0% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $17.0M | 44,721 | 1.0% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $15.0M | 2,194,278 | 0.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $14.3M | 510,441 | 0.8% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $13.5M | 1,013,505 | 0.8% |
| Agenus Inc(AGENEUR) | COM | 00847G705 | $13.0M | 15,656,234 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $11.2M | 2,382,835 | 0.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $10.4M | 352,397 | 0.6% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $9.7M | 429,395 | 0.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $9.4M | 222,553 | 0.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $7.6M | 131,000 | 0.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.1M | 174,838 | 0.4% |
| MoonLake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $6.9M | 113,757 | 0.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $4.1M | 19,000 | 0.2% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $3.8M | 331,099 | 0.2% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $3.1M | 2,754,437 | 0.2% |
| Nextcure Inc | COM | 65343E108 | $3.0M | 2,671,856 | 0.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $2.5M | 20,000 | 0.1% |
| Cooper Cos Inc | COM | 216648402 | $1.5M | 4,000 | 0.1% |
| Masimo Corp(MASI) | COM | 574795100 | $1.5M | 12,800 | 0.1% |
| Nucana PLC | SPONSORED ADR | 67022C106 | $1.4M | 4,684,120 | 0.1% |
| Agenus Inc(AGENEUR)Call | COM | 00847G705 | $1.3M | 1,600,000 | 0.1% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $1.2M | 125,299 | 0.1% |
| Marinus Pharmaceuticals Inc(MRNS*)Call | COM | 56854Q200 | $1.1M | 100,000 | 0.1% |